- Home
- PVBC vs THRD Comparison
PVBC vs THRD Comparison
Compare PVBC & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVBC
- THRD
- Stock Information
- Founded
- PVBC 1913
- THRD 2019
- Country
- PVBC United States
- THRD United States
- Employees
- PVBC N/A
- THRD N/A
- Industry
- PVBC Major Banks
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- PVBC Finance
- THRD Health Care
- Exchange
- PVBC Nasdaq
- THRD Nasdaq
- Market Cap
- PVBC 202.6M
- THRD 238.7M
- IPO Year
- PVBC 2015
- THRD 2022
- Fundamental
- Price
- PVBC $12.83
- THRD $5.46
- Analyst Decision
- PVBC Hold
- THRD Hold
- Analyst Count
- PVBC 1
- THRD 3
- Target Price
- PVBC $12.50
- THRD $5.00
- AVG Volume (30 Days)
- PVBC 251.0K
- THRD 217.6K
- Earning Date
- PVBC 07-28-2025
- THRD 08-07-2025
- Dividend Yield
- PVBC N/A
- THRD N/A
- EPS Growth
- PVBC N/A
- THRD N/A
- EPS
- PVBC 0.26
- THRD N/A
- Revenue
- PVBC $50,244,000.00
- THRD N/A
- Revenue This Year
- PVBC $9.73
- THRD N/A
- Revenue Next Year
- PVBC $4.87
- THRD N/A
- P/E Ratio
- PVBC $49.31
- THRD N/A
- Revenue Growth
- PVBC N/A
- THRD N/A
- 52 Week Low
- PVBC $9.67
- THRD $3.18
- 52 Week High
- PVBC $12.96
- THRD $16.02
- Technical
- Relative Strength Index (RSI)
- PVBC 78.85
- THRD 66.73
- Support Level
- PVBC $12.60
- THRD $5.42
- Resistance Level
- PVBC $12.83
- THRD $5.45
- Average True Range (ATR)
- PVBC 0.17
- THRD 0.04
- MACD
- PVBC 0.03
- THRD -0.01
- Stochastic Oscillator
- PVBC 91.15
- THRD 50.00
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.